Navigation Links
Chemoradiation in Medical News

Is Radiation or Chemoradiation Best for Oropharyngeal Cancer Patients

Patients with stage IV oropharyngeal cancer -- a type of cancer that develops in the part of the throat just behind the mouth// that assists with breathing, talking, eating, chewing, and swallowing -- are often treated with radiation alone or with chemoradiation. The addition of chemotherapy is usu...

Advanced targeted therapies effective as first-line treatment for lung cancer

...l 3. EFFICIENCY OF MAINTENANCE ERLOTINIB VERSUS PLACEBO IN PATIENTS WITH UNRESECTABLE STAGE III NON-SMALL LUNG CANCER (NSCLC) FOLLOWING CONCURRENT chemoradiation (D0410, NCT00153803) (ABSTRACT # C6.1) Currently, the role of maintenance therapy following concurrent treatment with chemotherapy and radiotherap...

NCCN Announces Updates to Pancreatic Adenocarcinoma Guidelines

...able disease. Dr. Tempero also provided additional clarification regarding the importance of upfront systemic therapy prior to administration of chemoradiation therapy stating that, "Radiation is important for a subset of patients with local disease only, but systemic chemotherapy should be given first." ...

MRI and PET/CT improve cervical cancer patient's chances for optimal treatment

...ely, spare them surgery and have them treated with chemoradiation alone," she said. Study results showed that while... if they were simply treated with surgery alone or chemoradiation alone. Our study shows how pre-treatment imaging m... improve chances of correctly receiving surgery or chemoradiation instead of both," said Dr. Pandharipande. "M...

CAPHOSOL results in minimal oral mucositis and pain in head/neck cancer patients

...aily for 76% of the days. Only four patients (7 percent) interrupted their chemoradiation regimen due to OM; none of these interruptions lasted longer than seven day...owing body of evidence supporting the use of CAPHOSOL from the beginning of chemoradiation therapy, as this rinse decreases the incidence and severity of oral mucosit...

Jefferson doctor receives Tree of Life award

...hell's research in pancreatic cancer and other GI malignancies involves new drug evaluation and chemotherapy, development of new therapeutic regimens, chemoradiation strategies for combined modality therapy, patient selection criteria and supportive care for patients with gastrointestinal cancer. She travels natio...

How to treat gastroesophageal adenocarcinom patients?

...atients diagnosed between 1996 and 1999 found that chemoradiation without surgery was most frequent therapy, although patients given chemoradiation followed by surgery had better survival compared to chemoradiation alone. Research suggests community-based use of tr...

HPV Tied to Better Tongue, Tonsil Cancer Outcomes

...idence of cancer, and 73 percent fully preserved their organs. Of the 11 patients referred for surgery, only four survived. "For most patients, the chemoradiation was very effective. But a subset of patients still do not do well. Our next step was to look at the biomarkers to see if we could determine which pati...

HPV linked to better survival in tonsil, tongue cancer, U-M study finds

...rapy and radiation went on to receive surgery. The researchers found that even with surgery, only 4 of 11 patients survived. For most patients, the chemoradiation was very effective. But a subset of patients still do not do well. Our next step was to look at the biomarkers to see if we could determine which pati...

Study finds cisplatin less effective than standard treatment for patients with anal cancer

...egy for treating the disease because previous studies have established that chemoradiation is more effective for smaller anal canal carcinomas than larger ones. "...nd colostomy-free survival relative to the continued standard of concurrent chemoradiation with fluorouracil and mitomycin. ...
Chemoradiation in Medical Technology

CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation

New Data Underscore the Utility of CAPHOSOL in Treating Oral Mucositis PRINCETON, N.J., May 21 /PRNewswire/ -- New data show that CAPHOSOL(R) (http://www.caphosol.com ), an advanced electrolyte solution, relieves painful oral mucositis (OM) and improves quality of life for cancer patients un...

TNFerade(TM) Phase III Data Presented at ASCO

...in/prnh/20081205/DC50112LOGO ) The poster , entitled "Multi-Center Randomized Controlled Phase III Clinical Trial using TNFerade(TM) with chemoradiation in Patients with Locally Advanced Pancreatic Cancer: Interim Analysis of Overall Survival," reported on results of an interim analysis from the PACT t...

Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients

...sion-free survival at three years for patients treated with the gemcitabine chemoradiation combination versus those treated only with chemoradiation (74% vs. 65%, respectively). Patients on the gemcitabine arm experienced s...

BioVex to Report Phase I/II Clinical Trial Results for the Front Line Treatment of Head and Neck Cancer With OncoVEX GM-CSF at the 2009 American Society of Clinical Oncology Meeting

...co.org , reports that OncoVEX GM-CSF was well tolerated, with no significant additional side effects noted over and above those which are common with chemoradiation alone. With respect to efficacy, 94% of patients had a complete pathological response noted at surgery, with five patients achieving a complete respon...

YM BioSciences Announces Milestone Payment For Approval Of Nimotuzumab In The Philippines And Indonesia

...y composition of free and liposome-encapsulated fentanyl. Nimotuzumab is in development targeting multiple tumour types in combination with radiation, chemoradiation and chemotherapy. The drug, which is approved for marketing in a number of countries, is significantly differentiated from all other currently markete...

GenVec Announces Update of Safety and Efficacy Data from Pivotal Phase II/III PACT Study of TNFerade at ASCO

...ewing session. The poster presentation, Multi-Center, Phase 2/3, Randomized, Controlled Clinical Trial using TNFerade(TM) Gene Delivery Combined with chemoradiation in Patients with Locally Advanced Pancreatic Cancer (LAPC), covered the most recent data from GenVec's Pancreatic Cancer Clinical Trial, known as the ...
Chemoradiation in Biological News

CAPHOSOL relieves oral mucositis and improves quality-of-life in cancer patients

...lyte Oral Rinse Aids Quality of Life for Head/Neck chemoradiation Patients" (Haas, ML), was selected by an ONS Exper...Neck Cancer Oral mucositis occurs in nearly all chemoradiation patients with HNC. Dr. Haas will present a subset...lyte Oral Rinse Aids Quality of Life for Head/Neck chemoradiation Patients. These data confirm high levels of pati...
Chemoradiation in Biological Technology

GenVec Reports Second Quarter 2009 Financial Results

...merican Society for Clinical Oncology. The poster , entitled "Multi-Center Randomized Controlled Phase III Clinical Trial using TNFerade(TM) with chemoradiation in Patients with Locally Advanced Pancreatic Cancer: Interim Analysis of Overall Survival," reported on results of an interim analysis from the PACT t...

YM BIOSCIENCES REPORTS DAIICHI-SANKYO ENROLLS FIRST PATIENTS IN PHASE II, FIRST-LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB

...y at the 2009 ASCO Annual Meeting from a randomized Phase IIb, four-arm, open-label trial of nimotuzumab in combination with radiation therapy (RT) or chemoradiation therapy (CRT) in patients with inoperable, locoregionally advanced Stage III/IVa head and neck cancer conducted in India by Reddy BK et al. The additi...

NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD & NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS

...umab in combination with radiation therapy (RT) or chemoradiation therapy (CRT) in patients with inoperable (Stage I... addition of nimotuzumab to both the radiation and chemoradiation regimens improved the overall response rate, survi...noclonal antibody against EGFR in combination with chemoradiation therapy or radiation therapy in patients with adva...

YM BIOSCIENCES ANNOUNCES RESULTS OF RANDOMIZED NIMOTUZUMAB STUDY TO BE PRESENTED IN A POSTER AT ASCO ANNUAL MEETING

...entitled "A phase IIb 4-arm open-label randomized study to assess the safety and efficacy of h-R3 monoclonal antibody against EGFR in combination with chemoradiation therapy or radiation therapy in patients with advanced (stage III or IVA) inoperable head and neck cancer (abstract # 6041)" will be presented in the ...

YM BIOSCIENCES REPORTS SECOND QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS

...model, towards approval and commercialization worldwide. Nimotuzumab is in development targeting multiple tumor types in combination with radiation, chemoradiation and chemotherapy. The humanized monoclonal antibody, which is approved for marketing in twelve of countries, is significantly differentiated from all ...

YM BIOSCIENCES RECEIVES CLEARANCE TO INITIATE RANDOMIZED DOUBLE-BLIND CLINICAL TRIALS OF NIMOTUZUMAB IN LUNG CANCER AND BRAIN METASTASES FROM LUNG CANCER

...y composition of free and liposome-encapsulated fentanyl. Nimotuzumab is in development targeting multiple tumour types in combination with radiation, chemoradiation and chemotherapy. The drug, which is approved for marketing in a number of countries, is significantly differentiated from all other currently markete...

YM BIOSCIENCES' NIMOTUZUMAB SELECTED FOR MULTINATIONAL PHASE III TRIAL BY NATIONAL CANCER CENTRE OF SINGAPORE

...y composition of free and liposome-encapsulated fentanyl. Nimotuzumab is in development targeting multiple tumour types in combination with radiation, chemoradiation and chemotherapy. The drug, which is approved for marketing in a number of countries, is significantly differentiated from all other currently markete...

YM BIOSCIENCES PROVIDES EU REGULATORY UPDATE

...y composition of free and liposome-encapsulated fentanyl. Nimotuzumab is in development targeting multiple tumour types in combination with radiation, chemoradiation and chemotherapy. The drug, which is approved for marketing in a number of countries, is significantly differentiated from all other currently markete...
Other Tags
(Date:12/25/2014)... 2014 Thousands of transvaginal mesh lawsuits ... a number of multidistrict litigations currently underway in U.S. ... LLP reports. According to an Order issued on December ... Joint Status Conference in all of the proceedings on ... directed to submit a proposed agenda to the Court ...
(Date:12/25/2014)... 2014 Plugin creators from Pixel Film ... fully customizable business presentation tool made specifically for ... 5k business tool, users can now display their stats ... Pixel Film Studios. “ProFire 5k gives users a multiple ... professionalism to a presentation” , Pixel Film Studios takes ...
(Date:12/25/2014)... Each year trauma accounts for approximately 42 ... across the nation (according to the Centers for ... Hospital Ambulatory Medical Care Survey collected data from ... They estimated that there were between 3.5 and 4.4 ... diagnosis of broken bone or fracture. , When ...
(Date:12/24/2014)... AlignLife of Wauwatosa loves helping those ... During the holiday season, AlignLife looks forward to their annual ... Dr. Sara Mahalko-Leonhardt, owner of AlignLife. "It brings our patients ... we are able to give kids toys for Christmas who ... the generosity of our patients." , The 70 toys were ...
(Date:12/24/2014)... 2014 Epigenetics finds applications in a ... oncology, drug discovery, developmental biology, and research for metabolic ... of the most widely used techniques for the discovery ... prevalence of cancer is rapidly growing worldwide. In 2012, ... cancer deaths, and 32.6 million people living with cancer ...
Breaking Medicine News(10 mins):Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 4Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 3Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 4Health News:AlignLife of Wauwatosa Brings Joy to Less Fortunate Families 2Health News:Global Epigenetics Market Was Valued at $413.24 Million in 2014 - New Research Report by MarketsandMarkets 2Health News:Global Epigenetics Market Was Valued at $413.24 Million in 2014 - New Research Report by MarketsandMarkets 3
(Date:12/11/2014)... 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition ... Region 2015-2019"  report to their offering. ... is advances in technology. With continuous advances in ... to the latest standard that meets the needs ...
(Date:12/10/2014)... YORK , Dec. 8, 2014 You,ve been ... banking account but can,t remember your password, site key or ... Who was your first grade teacher? Today, ... the app that will finally put an end ... – 1U TM . 1U leverages a user,s ...
(Date:12/10/2014)... Dec. 08, 2014 Research and Markets ... of the "Biometrics Market in Japan 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 The integration ... as rural banking and upgradation of the driver,s ... in the market. Besides the aforementioned projects, biometrics ...
Breaking Biology News(10 mins):Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2
Other Contents